ARTTX | RGACX | ARTTX / RGACX | |
Total Expense Ratio | 1.30 | 0.94 | 138% |
Annual Report Gross Expense Ratio | 1.30 | 0.94 | 138% |
Fund Existence | 8 years | 23 years | - |
Gain YTD | 3.305 | -2.667 | -124% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.01B | 285B | 0% |
Annual Yield % from dividends | 0.00 | 0.08 | - |
Returns for 1 year | 3.55 | 2.58 | 137% |
Returns for 3 years | 33.76 | 31.70 | 106% |
Returns for 5 years | 43.07 | 41.87 | 103% |
Returns for 10 years | N/A | 58.36 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EFAS | 16.97 | 0.17 | +1.01% |
Global X MSCI SuperDividend® EAFE ETF | |||
BBEU | 64.89 | 0.38 | +0.59% |
JPMorgan BetaBuilders Europe ETF | |||
PSDM | 50.87 | 0.10 | +0.20% |
PGIM Short Duration Mlt-Sect Bd ETF | |||
FLIA | 20.34 | -0.01 | -0.04% |
Franklin International Aggregate Bd ETF | |||
PJP | 78.43 | -0.97 | -1.22% |
Invesco Pharmaceuticals ETF |